Brief: Aridis Receives Agreement From The FDA On Single Confirmatory Phase 3 Study Of Ar-301 And The Clinical Study Design

Aridis Pharmaceuticals

31/05/2023 13:16

May 31 (Reuters) - Aridis Pharmaceuticals Inc  ARDS.O :
    * ARIDIS RECEIVES AGREEMENT FROM THE FDA ON A SINGLE
CONFIRMATORY
PHASE 3 STUDY OF AR-301 AND THE CLINICAL STUDY DESIGN
    * ARIDIS PHARMACEUTICALS INC - FDA AGREED ON DESIGN OF
SINGLE
CONFIRMATORY PHASE 3 SUPERIORITY STUDY REQUIRED TO SUPPORT
SUBMISSION OF A BLA
    * ARIDIS PHARMACEUTICALS - FDA AGREED TO PROPOSED EXPANSION
OF
CONFIRMATORY PHASE 3 STUDY IN S. AUREUS VAP TO INCLUDE
VENTILATED HAP & CAP PATIENTS

Source text for Eikon:  ID:nGNX30Lssh 
Further company coverage:  ARDS.O 

 ((Reuters.Briefs@thomsonreuters.com;))